DRUG CIK: 1827401

Bright Minds Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions CAD
FY21:
−7.32
FY22:
−13.6
FY23:
−7.02
FY24:
−1.85
FY25:
−8.69
Change from FY21 to FY25
millions CAD
FY21:
26.1
FY22:
5.20
FY23:
2.19
FY24:
0.81
FY25:
85.6
millions CAD
FY21:
18.7
FY22:
−8.39
FY23:
−4.83
FY24:
−1.04
FY25:
76.9

All amounts in millions CAD Data source:SEC EDGAR